Difficulty: Medium
Average Score: 88%
Practice
Which of the following thrombolytic agents would be appropriate at this time?
Correct answer
C
Rationale
In this scenario, the correct thrombolytic agent to use is option C) Recombinant tissue-type plasminogen activator (t-PA). Tissue plasminogen activators like t-PA are preferred over streptokinase-based agents due to their higher specificity for fibrin-bound plasminogen, which leads to localized clot lysis and reduced systemic activation of plasmin. This specificity reduces the risk of bleeding complications associated with non-fibrin-specific agents like streptokinase.
Option A) Anisoylated plasminogen streptokinase activator complex (APSAC) is not commonly used anymore due to its association with increased allergic reactions. Option B) Streptokinase (SK) is less specific than t-PA and can lead to more systemic plasmin activation, increasing the risk of bleeding complications.
Educationally, understanding the differences in thrombolytic agents is crucial for healthcare providers to make informed decisions in managing patients with thrombotic disorders. By knowing the mechanism of action, indications, contraindications, and potential side effects of each agent, healthcare professionals can tailor treatment to individual patients, optimizing outcomes while minimizing risks.
Option A) Anisoylated plasminogen streptokinase activator complex (APSAC) is not commonly used anymore due to its association with increased allergic reactions. Option B) Streptokinase (SK) is less specific than t-PA and can lead to more systemic plasmin activation, increasing the risk of bleeding complications.
Educationally, understanding the differences in thrombolytic agents is crucial for healthcare providers to make informed decisions in managing patients with thrombotic disorders. By knowing the mechanism of action, indications, contraindications, and potential side effects of each agent, healthcare professionals can tailor treatment to individual patients, optimizing outcomes while minimizing risks.